Bullous pemphigoid (BP) is the most common autoimmune subepidermal blistering disorder, representing 80% of subepidermal immunobullous cases. Bullous pemphigoid most commonly affects elderly patients between the ages of 60 to 80 years. This activity reviews the etiology, presentation, evaluation, and management of bullous pemphigoid and reviews the interprofessional team's role in evaluating, diagnosing, and managing the condition.

**Objectives:**
- Review the etiology of bullous pemphigoid.
- Describe the pathophysiology of bullous pemphigoid.
- Summarize the management options for bullous pemphigoid
- Outline possible interprofessional team strategies for improving care coordination and communication to advance the evaluation and treatment of bullous pemphigoid and improve outcomes.